FDA Import Refusal 9NK-0021654-7/12/1I — Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
The FDA refused shipment 9NK-0021654-7/12/1I from Guangzhou Baiyunshan Pharmaceutical Co., Ltd. (China) on October 3, 2023. The refused product falls under Drugs and Biologics — ERYTHROMYCIN (MACROLIDES). Cited charges: 472,75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- October 3, 2023
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 56ICJ10 ERYTHROMYCIN (MACROLIDES)
- Charges
- 472,75